Evidence Hub

Proliferative glomerulonephritis with monoclonal immunoglobulin IgG1-κ deposition in a patient with type 1 diabetes: a case report and literature review

Li X, Zhang X, Dai X, Zhang Y, Lan T, Li J, Wu M, Jia T et al.

Frontiers in medicine, 2026

Abstract

Background: Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) is a rare glomerular disease characterized by edema, proteinuria, and renal insufficiency. No established treatment protocol is currently available. We report a case of PGNMID with monoclonal IgG1-κ deposits in a patient with a 19-year history of type 1 diabetes.

Case presentation: A 30-year-old woman presented with a 1-week history of nausea, vomiting, and generalized edema. She had a 19-year history of type 1 diabetes mellitus with poor glycemic control. Three months before admission, she had been hospitalized for fever and was diagnosed with a urinary tract infection, during which her renal function was normal. After discharge, she continued to experience recurrent episodes of fever. One week before admission, she gradually developed generalized edema accompanied by decreased urine output. On admission, she was found to have nephrotic-range proteinuria, hypoalbuminemia, anemia, acute renal failure, and acute heart failure. After antimicrobial therapy, renal replacement therapy, and nutritional support, the patient underwent renal biopsy. Immunofluorescence showed diffuse, global, granular, and lumpy deposits of IgG, C3, and κ light chain along the glomerular capillary loops and in the mesangial regions, with strong IgG1 positivity. Electron microscopy revealed proliferation of glomerular capillary endothelial cells, accompanied by segmental mesangial matrix interposition into the…

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free